Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Bowen

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Internal Medicine Journal|May 10, 2022
Safety first, a harmful interaction between rivaroxaban and berberineMark Bonnichsen, Ted Stoklosa, David Bowen, et al.
Haematologica|September 13, 2003
Antioxidant enzyme expression in myelodysplastic and acute myeloid leukemia bone marrow: further evidence of a pathogenetic role for oxidative stress?David Bowen, Lihui Wang, Marion Frew, et al.
Journal of Insurance Medicine (New York, N.Y.)|August 2, 2021
Projection of Impaired Life Expectancy in Individuals in the United Kingdom Using Mortality RatiosDavid Bowen Jones, Nicole R Gray, Madeleine Reid, et al.
Journal of Insurance Medicine (New York, N.Y.)|August 2, 2021
Projection of Impaired Life Expectancy for Individuals in the United Kingdom Using Estimated Excess Death RatesDavid Bowen Jones, Nicole R Gray, Madeleine Reid, et al.
Postgraduate Medical Journal|August 21, 2012
Falling mortality rates in Type 2 diabetes mellitus in the Wirral Peninsula: a longitudinal and retrospective cohort population-based studyChukwuemeka Nwaneri, David Bowen-Jones, Helen Cooper, et al.
Leukemia Research|December 21, 2004
Thalidomide therapy for low-risk MyelodysplasiaDavid Bowen, Louisa MacIlwaine, Jamie Cavanagh, et al.
Haematologica|September 2, 2004
No increase in age-specific incidence of myelodysplastic syndromesUlrich Germing, Corinna Strupp, Andrea Kündgen, et al.
British Journal of Haematology|January 25, 2003
Guidelines for the diagnosis and therapy of adult myelodysplastic syndromesDavid Bowen, Dominic Culligan, Simon Jowitt, et al.
FEMS Microbiology Letters|September 28, 2002
The lumicins: novel bacteriocins from Photorhabdus luminescens with similarity to the uropathogenic-specific protein (USP) from uropathogenic Escherichia coliSadhana Sharma, Nicholas Waterfield, David Bowen, et al.
British Journal of Haematology|May 25, 2002
Allele and haplotype frequency at human leucocyte antigen class I/II and immunomodulatory cytokine loci in patients with myelodysplasia and acute myeloid leukaemia: in search of an autoimmune aetiologyDuncan Gowans, Alan O'Sullivan, Sara Rollinson, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Internal Medicine Journal|May 10, 2022
Safety first, a harmful interaction between rivaroxaban and berberineMark Bonnichsen, Ted Stoklosa, David Bowen, et al.
Haematologica|September 13, 2003
Antioxidant enzyme expression in myelodysplastic and acute myeloid leukemia bone marrow: further evidence of a pathogenetic role for oxidative stress?David Bowen, Lihui Wang, Marion Frew, et al.
Journal of Insurance Medicine (New York, N.Y.)|August 2, 2021
Projection of Impaired Life Expectancy in Individuals in the United Kingdom Using Mortality RatiosDavid Bowen Jones, Nicole R Gray, Madeleine Reid, et al.
Journal of Insurance Medicine (New York, N.Y.)|August 2, 2021
Projection of Impaired Life Expectancy for Individuals in the United Kingdom Using Estimated Excess Death RatesDavid Bowen Jones, Nicole R Gray, Madeleine Reid, et al.
Postgraduate Medical Journal|August 21, 2012
Falling mortality rates in Type 2 diabetes mellitus in the Wirral Peninsula: a longitudinal and retrospective cohort population-based studyChukwuemeka Nwaneri, David Bowen-Jones, Helen Cooper, et al.
Leukemia Research|December 21, 2004
Thalidomide therapy for low-risk MyelodysplasiaDavid Bowen, Louisa MacIlwaine, Jamie Cavanagh, et al.
Haematologica|September 2, 2004
No increase in age-specific incidence of myelodysplastic syndromesUlrich Germing, Corinna Strupp, Andrea Kündgen, et al.
British Journal of Haematology|January 25, 2003
Guidelines for the diagnosis and therapy of adult myelodysplastic syndromesDavid Bowen, Dominic Culligan, Simon Jowitt, et al.
FEMS Microbiology Letters|September 28, 2002
The lumicins: novel bacteriocins from Photorhabdus luminescens with similarity to the uropathogenic-specific protein (USP) from uropathogenic Escherichia coliSadhana Sharma, Nicholas Waterfield, David Bowen, et al.
British Journal of Haematology|May 25, 2002
Allele and haplotype frequency at human leucocyte antigen class I/II and immunomodulatory cytokine loci in patients with myelodysplasia and acute myeloid leukaemia: in search of an autoimmune aetiologyDuncan Gowans, Alan O'Sullivan, Sara Rollinson, et al.
Pageof 10